Printer Friendly

GENSIA HIRES NEW RESEARCH DIRECTORS IN CENTRAL NERVOUS SYSTEM PHARMACOLOGY AND IMMUNOLOGY

               GENSIA HIRES NEW RESEARCH DIRECTORS IN
         CENTRAL NERVOUS SYSTEM PHARMACOLOGY AND IMMUNOLOGY
    SAN DIEGO, July 21 /PRNewswire/ -- Gensia Pharmaceuticals Inc. (NASDAQ: GNSA) today announced that Alan C. Foster, Ph.D., has joined the company as director of central nervous system (CNS) pharmacology, and Gary S. Firestein, M.D., has joined the company as director of immunology.  Foster will direct Gensia research programs in cerebrovascular and neurological diseases, and Firestein will develop and manage Gensia's research program in inflammation.
    "The addition of Drs. Foster and Firestein to our research staff indicates our commitment to the expansion of Gensia's research efforts with our purine and pyrimidine technology in the treatment of CNS and immunologic disorders," said David F. Hale, chairman, president and chief executive officer.  "They each have extensive experience in their respective fields which will allow us to build our capabilities in these areas rapidly.  We are very pleased to have them join our research team."
    Before joining Gensia, Foster spent eight years at Merck, Sharpe and Dohme Ltd., most recently as a section leader in the Neuroscience Research Centre in Essex, England.  Foster was awarded a bachelor's degree in physiology and biochemistry and a Ph.D. in neuropharmacology from the University of Southampton in England.  He conducted postdoctoral research at the University of California, Irvine and the University of Maryland School of Medicine, is a member of the British Pharmacological Society and the Society for Neuroscience and is a noted speaker on neurochemistry and excitatory amino acids.
    Prior to joining Gensia, Firestein was assistant professor of medicine in residence at the University of California, San Diego where he has been employed in the division of rheumatology for nine years.  Firestein holds a bachelor's degree in chemistry from Harvard University and was awarded a medical degree from Johns Hopkins University, School of Medicine.  He is a member of the American College of Rheumatology and recently received the Henry Christian Award for Excellence in Research from the American Federation for Clinical Research.
    Gensia Pharmaceuticals is a San Diego-based biopharmaceutical company formed to discover, develop, manufacture and market novel pharmaceutical products for the treatment and diagnosis of human diseases.
    -0-                     7/21/92
    /CONTACT:  Martha L. Hough or Elizabeth Gard of Gensia Pharmaceuticals, 619-546-8300/
    (GNSA) CO:  Gensia Pharmaceuticals Inc. ST:  California IN:  MTC SU:  PER KJ-CH -- SD001 -- 1316 07/21/92 12:02 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 21, 1992
Words:391
Previous Article:BANC ONE INCREASES CASH DIVIDEND TO $.32 PER SHARE
Next Article:IMMUNEX ELECTS TOM MIZELLE VICE PRESIDENT, SALES AND MARKETING
Topics:


Related Articles
GENSIA AND SANDOZ SIGN AGREEMENT FOR DIABETES RESEARCH
NICHOLAS YEO JOINS GENSIA EUROPE LTD. AS DIRECTOR OF MARKETING - EUROPE
SIBIA NAMES FORMER WYETH-AYERST EXEC AS SENIOR DIRECTOR OF PHARMACOLOGY AND PRECLINICAL DEVELOPMENT
GENVEC ANNOUNCES NEW VICE PRESIDENT OF DEVELOPMENT
GUILFORD PHARMACEUTICALS APPOINTS TWO SENIOR EXECUTIVES
DR. SOL I. RAJFER APPOINTED TO BRISTOL-MYERS SQUIBB SR. VICE PRESIDENT WORLDWIDE CLINICAL R&D
Cognetix Hires Davis L. Temple as Chairman and CEO Industry Veteran to Head Biopharmaceutical Research and Development Company
Gensia Sicor Announces Management Appointments
NitroMed Promotes David S. Garvey, Ph.D., to Senior Director of Chemistry and S. William Tam, Ph.D., to Senior Director of Biology
Kendle Names Dr. Bruce Kreter Vice President of Clinical Development and Announces Key European Management Appointments.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters